HLA-DR2+ intermediate uveitis

W. M. Tang, J. S. Pulido, D. P. Han, W. F. Mieler

Research output: Contribution to journalArticle


Purpose. To evaluate the clinical features of HLA-DR2+ intermediate uveitis. Methods. We present 13 consecutive cases of HLA-DR2+ intermediate uveitis, with specific attention to ophthalmological features, co-existing systemic disorders, and family histories. Seven consecutive cases of HLA-DR2 negative intermediate uveitis are presented for comparison. Results. Eight out of 13 HLA-DR2+ patients have retinal periphlebitis. Five patients have a history of another HLA-DR2 related disorder: 3 have multiple sclerosis, 1 has idiopathic optic neuritis, 1 has narcolepsy. HLA sub-serotyping revealed that all patients carried the HLA-DR15,DQ6 haplotype, which is the haplotype most commonly found in multiple sclerosis. Conclusion. HLA-DR2+ intermediate uveitis is a distinct clinical entity. Affected patients and their family members may be at increased risk for developing a group of HLA-DR2 related disorders, most notably multiple sclerosis.

Original languageEnglish (US)
Pages (from-to)S1038
JournalInvestigative Ophthalmology and Visual Science
Issue number3
StatePublished - Feb 15 1996

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'HLA-DR2+ intermediate uveitis'. Together they form a unique fingerprint.

  • Cite this

    Tang, W. M., Pulido, J. S., Han, D. P., & Mieler, W. F. (1996). HLA-DR2+ intermediate uveitis. Investigative Ophthalmology and Visual Science, 37(3), S1038.